KIT and glioblastoma: Remarkably, most samples harbored activating alterations in receptor tyrosine kinases (RTKs), including frequent co-amplifications and fusions of the KDR and KIT genes located on 4q12, as well as other mutations involving p53, cell cycle regulators, and genes frequently mutated in glioblastoma (Fig. 3B).